REG - CVS Group plc - Exercise of SAYE Options and PDMR Dealing

CVSAnnouncement

10/01/2023 12:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230110:nRSJ2763Ma&default-theme=true

RNS Number : 2763M  CVS Group plc  10 January 2023

10 January 2023

 

CVS Group Plc

("CVS" or the "Company")

Exercise of SAYE Options, PDMR Dealing

and Total Voting Rights

CVS, one of the UK's leading providers of integrated veterinary services,
announces that on 10 January 2023, options over a total of 106,955 ordinary
shares of 0.2 pence each (the "Ordinary Shares") were exercised under the CVS
Group 2019 SAYE Plan (2019/2023), at an exercise price of £8.63.
Additionally, deferred options over a total of 1,474 Ordinary Shares were
exercised under the CVS Group 2018 SAYE Plan (2018/2022) taking the total
options exercised on 10 January 2023 to 108,429.

The sum of 108,429 new Ordinary Shares were issued to satisfy the balance of
Ordinary Shares arising from the SAYE Exercise.  Admission of the 108,429 new
Ordinary Shares has been satisfied by the Company's block listing admitted to
the London Stock Exchange on 30 December 2021.

Robin Alfonso, Chief Financial Officer exercised options over 709 Ordinary
Shares in the Company.  The balance of the options were exercised by certain
other employees and former employees of the Company.

Following his option exercise, Robin Alfonso holds a beneficial interest in
12,151 Ordinary Shares in the Company, representing approximately 0.017 per
cent of the total voting rights of the Company, calculated on the same basis.

Following the issue of the new Ordinary Shares, the Company has a total issued
share capital of 71,380,400 Ordinary Shares each carrying one voting right.
The Company holds no Ordinary Shares in treasury. Therefore, following the
issue of the new Ordinary Shares, the total number of voting rights in the
Company will be 71,380,400. This figure may be used by shareholders as the
denominator for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest in, the
Company under the FCA's Disclosure Guidance and Transparency Rules.

The notification below, made in accordance with the requirements of the UK
Market Abuse Regulation, provides further detail.

Contacts:

CVS Group
plc
via Camarco

Richard Fairman, CEO

Jenny Farrer, Company Secretary

 

Peel Hunt LLP (Nominated Adviser & Broker)
                          +44 (0)20 7418 8900

Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose

 

   Berenberg (Joint Broker)
 
 +44 (0)20 3207 7800

Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser

 

Camarco (Financial
PR)

Geoffrey Pelham-Lane
 
+44 (0)7733 124 226

Ginny
Pulbrook
+44 (0)7961 315 138

   Toby
Strong
+44 (0)7789 151 644

 

 

 

 

 

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them

 

 1   Details of the person discharging managerial responsibilities / person closely
     associated
 a)  Name                                      Robin Alfonso
 2   Reason for the notification
 a)  Position/status                           Chief Financial Officer
 b)  Initial notification /Amendment           Initial Notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                      CVS Group plc
 b)  LEI                                       213800J41XDQ2NX48O05
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted

 a)  Description of the financial instrument, type of instrument  Ordinary shares of 0.2 pence each

     Identification code                                          GB00B2863827
 b)  Nature of the transaction                                    Exercise of options under the 2019 SAYE Plan (1 January   2023 maturity)

 c)  Price(s) and volume(s)                                       Price(s)   Volume
                                                                    £8.63    709

 

 

 

 d)  Aggregated information

     - Aggregated volume

                                                                  N/A - single transaction

     - Price
 e)  Date of the transaction                                      10 January 2023
 f)  Place of the transaction                                     London Stock Exchange - AIM

 

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

N/A - single transaction

e)

Date of the transaction

10 January 2023

f)

Place of the transaction

London Stock Exchange - AIM

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHLBLFFXFLFBBX